-
Tytuł:
-
Resurgence of SARS-CoV-2: Detection by community viral surveillance.
-
Autorzy:
-
Riley S; School of Public Health, Imperial College London, London, UK. .; MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
Ainslie KEC; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
Eales O; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
Walters CE; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
Wang H; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
Atchison C; School of Public Health, Imperial College London, London, UK.
Fronterre C; Centre for Health Informatics, Computing, and Statistics (CHICAS), Lancaster Medical School, Lancaster University, Lancaster, UK.; Health Data Research UK, London, UK.
Diggle PJ; Centre for Health Informatics, Computing, and Statistics (CHICAS), Lancaster Medical School, Lancaster University, Lancaster, UK.; Health Data Research UK, London, UK.
Ashby D; School of Public Health, Imperial College London, London, UK.
Donnelly CA; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.; Department of Statistics, University of Oxford, Oxford, UK.
Cooke G; Department of Infectious Disease, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.
Barclay W; Department of Infectious Disease, Imperial College London, London, UK.
Ward H; School of Public Health, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.
Darzi A; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.; Institute of Global Health Innovation, Imperial College London, London, UK.
Elliott P; School of Public Health, Imperial College London, London, UK. .; Imperial College Healthcare NHS Trust, London, UK.; National Institute for Health Research Imperial Biomedical Research Centre, London, UK.; MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.
-
Źródło:
-
Science (New York, N.Y.) [Science] 2021 May 28; Vol. 372 (6545), pp. 990-995. Date of Electronic Publication: 2021 Apr 23.
-
Typ publikacji:
-
Journal Article; Research Support, Non-U.S. Gov't
-
Język:
-
English
-
Imprint Name(s):
-
Publication: : Washington, DC : American Association for the Advancement of Science
Original Publication: New York, N.Y. : [s.n.] 1880-
-
MeSH Terms:
-
Epidemiological Monitoring*
Public Health Surveillance*
COVID-19/*epidemiology
Adolescent ; Adult ; Aged ; Basic Reproduction Number ; COVID-19/diagnosis ; COVID-19 Nucleic Acid Testing ; Child ; Child, Preschool ; England/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Prevalence ; SARS-CoV-2 ; Young Adult
-
References:
-
Proc Biol Sci. 2007 Feb 22;274(1609):599-604. (PMID: 17476782)
Wellcome Open Res. 2020 Aug 25;5:200. (PMID: 33997297)
Lancet. 2021 Jan 9;397(10269):99-111. (PMID: 33306989)
Lancet Infect Dis. 2020 Jun;20(6):669-677. (PMID: 32240634)
PLoS Comput Biol. 2017 Nov 20;13(11):e1005838. (PMID: 29155812)
J Infect. 2020 Sep;81(3):411-419. (PMID: 32504743)
Nat Rev Immunol. 2020 Oct;20(10):615-632. (PMID: 32887954)
Front Public Health. 2022 Jan 03;9:561710. (PMID: 35047467)
Trop Med Infect Dis. 2019 Jan 11;4(1):. (PMID: 30641917)
Am J Infect Control. 2021 Jan;49(1):21-29. (PMID: 32659413)
Ann Intern Med. 2020 Aug 18;173(4):262-267. (PMID: 32422057)
Contemp Econ Policy. 2020 Oct;38(4):583-592. (PMID: 32837176)
Nat Med. 2021 Apr;27(4):622-625. (PMID: 33654292)
Nat Commun. 2020 Nov 20;11(1):5917. (PMID: 33219229)
Lancet Infect Dis. 2020 Aug;20(8):911-919. (PMID: 32353347)
BMC Med. 2020 May 7;18(1):124. (PMID: 32375776)
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6. (PMID: 33592168)
Nat Commun. 2021 Feb 10;12(1):905. (PMID: 33568663)
Elife. 2020 May 11;9:. (PMID: 32392129)
Science. 2020 Jun 19;368(6497):1362-1367. (PMID: 32371477)
Wellcome Open Res. 2020 Jul 17;5:170. (PMID: 32954015)
Nature. 2020 Aug;584(7820):257-261. (PMID: 32512579)
Science. 2020 Jun 26;368(6498):1481-1486. (PMID: 32350060)
N Engl J Med. 2020 Dec 17;383(25):2427-2438. (PMID: 32991794)
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13422-7. (PMID: 23882078)
Nat Med. 2020 Aug;26(8):1205-1211. (PMID: 32546824)
Science. 2021 May 7;372(6542):635-641. (PMID: 33758017)
N Engl J Med. 2020 Dec 31;383(27):2603-2615. (PMID: 33301246)
BMJ. 2020 Dec 16;371:m4857. (PMID: 33328153)
PLoS Med. 2008 Mar 25;5(3):e74. (PMID: 18366252)
BMJ. 2020 Dec 2;371:m4714. (PMID: 33268330)
Lancet Infect Dis. 2020 Jul;20(7):769-770. (PMID: 32445713)
-
Grant Information:
-
MC_PC_19012 United Kingdom MRC_ Medical Research Council; MC_PC_20029 United Kingdom MRC_ Medical Research Council; MR/J008761/1 United Kingdom MRC_ Medical Research Council; United Kingdom WT_ Wellcome Trust; MR/R015600/1 United Kingdom MRC_ Medical Research Council
-
Entry Date(s):
-
Date Created: 20210424 Date Completed: 20210611 Latest Revision: 20240402
-
Update Code:
-
20240402
-
PubMed Central ID:
-
PMC8158959
-
DOI:
-
10.1126/science.abf0874
-
PMID:
-
33893241
-
Surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has mainly relied on case reporting, which is biased by health service performance, test availability, and test-seeking behaviors. We report a community-wide national representative surveillance program in England based on self-administered swab results from ~594,000 individuals tested for SARS-CoV-2, regardless of symptoms, between May and the beginning of September 2020. The epidemic declined between May and July 2020 but then increased gradually from mid-August, accelerating into early September 2020 at the start of the second wave. When compared with cases detected through routine surveillance, we report here a longer period of decline and a younger age distribution. Representative community sampling for SARS-CoV-2 can substantially improve situational awareness and feed into the public health response even at low prevalence.
(Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
